[Nadolol in the preventive treatment of migraine].
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000328:Adult; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000517:prevention & control*; D009248:Nadolol; D010919:Placebos; D011412:Propanolamines / Q000008:administration & dosage*; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D010919:Placebos; D011412:Propanolamines; D009248:Nadolol
Nadolol w profilaktycznym leczeniu migreny.